# ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Study · id `cardio:ct-nct05879913` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05879913](<https://clinicaltrials.gov/study/NCT05879913>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05879913

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05879913. Randomized; no masking; primary purpose diagnostic. Start 2023-12-15 (actual); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05879913, source copy `cardio:ctgov-nct05879913-2026-10-05`, retrieved 2026-10-26)
- Started: 2023-12-15 (actual) (ClinicalTrials.gov record NCT05879913, source copy `cardio:ctgov-nct05879913-2026-10-05`, retrieved 2026-10-26)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05879913, source copy `cardio:ctgov-nct05879913-2026-10-05`, retrieved 2026-10-26)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT05879913, source copy `cardio:ctgov-nct05879913-2026-10-05`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05879913, source copy `cardio:ctgov-nct05879913-2026-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05879913-2026-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
- Condition: Prostate Cancer
- Intervention (Device): Coronary CT Angiography (CCTA)
- Lead sponsor: Indiana University
- Lead sponsor class: OTHER
- Collaborator: National Comprehensive Cancer Network
- Collaborator class: NETWORK
- Collaborator: Pfizer
- Collaborator class: INDUSTRY
- Collaborator: Sumitomo Pharma America, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Indiana University (`cardio:org-indiana-university`)
- Registry lists this organization as a collaborator: Pfizer (`cardio:org-pfizer`)

## Provenance

Content hash: c0f21fb0b4f7ae67e44193083299234485d518daa09252149000df1ce09c5675
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
